Research Site

Paramus, New Jersey 07652

3 studies enrolling now · 11 studies all time

What they study most

Asthma, Carcinoma, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, EGFR T790M Mutation Positive NSCLC, Endometrial Cancer, Endometrial Neoplasms, Locally Advanced (Inoperable) or Metastatic Breast Cancer, Malignant Solid Tumour, Metastases, Metastatic Castration-resistant Prostate Cancer, Neoplasm

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) — Recruiting now
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma — Recruiting now
• Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer — Running, not enrolling
• Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation — Running, not enrolling
• Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer — Running, not enrolling
• Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer — Running, not enrolling
• AZD9291 US Expanded Access Program — NO_LONGER_AVAILABLE
• A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder — Completed
• Iressa Expanded Access Program (EAP) — Completed
• Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia — Completed